GLP-1 Drugs Revolutionizing Weight and Health | Washington DC News

GLP-1 drugs like Ozempic and Wegovy are revolutionizing weight management and chronic disease prevention, with usage skyrocketing from 3% to 11% of adults for weight loss in just two years—and nearly 15% of all users. Awareness has exploded, with 91% now recognizing the drugs, fueled by FDA approvals and broader access. Public health is shifting too: obesity rates have dipped from nearly 40% to 36.4%, and diabetes diagnoses have stabilized since 2023. Most users stick with brand-name meds (68%), but 19% opt for cheaper compounded versions. These drugs aren’t just helping people lose weight—they’re reshaping national health outcomes. Thank you to our sponsor Garrett Waller Performance: http://coaching.garrettwaller.com Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/c6c91ab19d56e364